Founded in 1912 and published monthly, Strahlentherapie und Onkologie is a scientific journal that covers all aspects of oncology with focus on radiooncology, radiation biology and radiation physics. The articles are of interest not only to radiooncologists but to all physicians interested in oncology, as well as to radiation biologists and radiation physicists. The peer-reviewed journal publishes original articles, review articles and case studies, scientific short communications and a literature review with annotated articles that inform the reader of new developments in the disciplines concerned. This allows for a sound overview of the latest results in radiooncology research.
Contributions are published in English. The journal is the official publication of several scientific radiooncological societies and publishes the relevant communications of these societies.
- Founded in 1912, the oldest oncological journal
- Covers all aspects of oncology with focus on radiooncology, radiation biology and radiation physics
- Publishes original articles, review articles, case studies and short communications
- Includes a literature review with annotated articles
Journal information
- Editor-in-Chief
-
- Rainer Fietkau,
- Frederik Wenz
- Publishing model
- Hybrid. Open Access options available
Journal metrics
- 2.899 (2019)
- Impact factor
- 2.500 (2019)
- Five year impact factor
- 38 days
- Submission to first decision
- 134 days
- Submission to acceptance
- 133,570 (2019)
- Downloads
Latest issue
Latest articles
-
-
Prospective evaluation of multitarget treatment of pediatric patients with helical intensity-modulated radiotherapy
Authors (first, second and last of 6)
-
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
Authors (first, second and last of 16)
-
The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma
Authors (first, second and last of 5)
-
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
Authors (first, second and last of 10)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Societies, partners and affiliations
-
Hellenic Society of Radiation Oncology
About this journal
- Electronic ISSN
- 1439-099X
- Print ISSN
- 0179-7158
- Abstracted and indexed in
-
- BIOSIS
- Biological Abstracts
- CNKI
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO CINAHL
- EBSCO Discovery Service
- EMBASE
- EMCare
- FIZ Karlsruhe
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Advanced Technologies & Aerospace Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Nursing & Allied Health Database
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Psyndex
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- UGC-CARE List (India)
- Copyright information
